There is movement afoot in the US to improve transparency and set limitations on litigation financed by third parties, which has increased drastically in the past decade with costly implications for medical device manufacturers.
In fact, third-party litigation funding (TPLF) is the driving force behind most medical device litigation in the US, according to...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?